Is Legend Biotech (LEGN) One of the Overlooked Growth Stocks to Buy Now?

Legend Biotech Corporation (NASDAQ:LEGN) is 1 of the overlooked maturation stocks to bargain now. Earlier connected March 10, Legend Biotech reported fiscal results for the afloat twelvemonth 2025, headlined by the continued commercialized occurrence of its aggregate myeloma therapy, CARVYKTI. The attraction generated nett commercialized income of ~$555 cardinal successful Q4 and $1.9 cardinal for 2025, starring the CARVYKTI franchise to execute full-year profitability.

This maturation was supported by a important summation successful collaboration revenue, which roseate to $277.6 cardinal successful the last quarter. The institution reached a large objective milestone successful 2025, surpassing 10,000 patients treated with CARVYKT crossed objective and commercialized settings. To enactment this rising demand, Legend Biotech expanded its Raritan manufacturing facility, making it the largest compartment therapy accumulation tract successful the US with the capableness to dainty 10,000 patients annually.

Mila Supinskaya Glashchenko/Shutterstock.com

The therapy’s planetary footprint besides grew to 294 sites crossed 14 markets, with a absorption connected expanding adoption wrong the US assemblage and outpatient settings. New information presented astatine large aesculapian meetings continued to reenforce the durable outcomes associated with utilizing the therapy successful earlier lines of treatment. Beyond its flagship product, Legend Biotech Corporation (NASDAQ:LEGN) precocious its early-stage pipeline and probe infrastructure. The institution opened a caller 31,000-square-foot R&D installation successful Philadelphia and achieved first-patient dosing for its successful vivo pipeline candidates.

Legend Biotech Corporation (NASDAQ:LEGN) is simply a clinical-stage institution that develops, discovers, manufactures, and commercializes caller therapies for oncology and different indications. It develops precocious compartment therapies crossed an elaborate scope of exertion platforms.

While we admit the imaginable of LEGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.